Scleroderma-associated interstitial lung disease is the most common complication leading to death of patients with systemic sclerosis

Ended Project Grant Awarded Last action

Award ID
W81XWH2210511
Recipient
Awarding agency
Obligated
$692,838

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Pittsburgh, PA 15260, USA

Award details come from USAspending.gov.

About this award

The University of Pittsburgh received a three-year Project Grant award of $692,838 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into scleroderma-associated interstitial lung disease, the most common cause of death for patients with systemic sclerosis. Through June 2025, the University of Pittsburgh will investigate medical solutions for this complication as part of the program's mission to transform military and public health through innovative medical research solutions applicable to battlefield wounds. The research will be conducted in Pittsburgh, Pennsylvania.

Quick answers

Who received award W81XWH2210511?

W81XWH2210511 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by Medical Command (Department of the Army) on July 1, 2022.

How much is award W81XWH2210511 worth?

$692,838 has been obligated on W81XWH2210511.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award